Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C18H21NO3.ClH |
Molecular Weight | 335.825 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.[H][C@]12CC3=CC=C(O)C4=C3[C@]5(CCN1C)[C@@]2([H])CCC(=O)[C@]5(C)O4
InChI
InChIKey=IUIZPWPENLRTFZ-RNWHKREASA-N
InChI=1S/C18H21NO3.ClH/c1-17-14(21)6-4-11-12-9-10-3-5-13(20)16(22-17)15(10)18(11,17)7-8-19(12)2;/h3,5,11-12,20H,4,6-9H2,1-2H3;1H/t11-,12+,17-,18-;/m0./s1
Molecular Formula | C18H21NO3 |
Molecular Weight | 299.3642 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Metopon was developed as an analgesic opium derivative. This drug has a high affinity to the mu-opioid receptor and produces antinociception through this receptor. Metopon was available in Canada only in tablet form for oral administration; however, because of the drug addiction, the Drug Addiction Committee recommended its limited use.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Metopon. | 1947 Sep |
|
Metopon hydrochloride (methyldihydromorphinone hydrochloride). | 1948 Jan |
|
METOPON hydrochloride, alcohol-dextrose, dextrose vitamin solutions. | 1948 Jul |
|
Pharmacology of metopon and other new analgesic opium derivatives. | 1948 Nov 1 |
|
A comparison of the actions of meperidine, Nu-1196, methadone, morphine, Nu-2206, and metopon upon the intestine and uterus. | 1950 Jul |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18897557
Metopon will be available in Canada only in tablet form for oral administration. The tablets will be put up in bottles of 50 and each tablet will contain 8.0 mgm. of metopon hydrochloride.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 14:59:38 GMT 2023
by
admin
on
Fri Dec 15 14:59:38 GMT 2023
|
Record UNII |
6O34Q1K8M6
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
9260
Created by
admin on Fri Dec 15 14:59:38 GMT 2023 , Edited by admin on Fri Dec 15 14:59:38 GMT 2023
|
||
|
NCI_THESAURUS |
C67413
Created by
admin on Fri Dec 15 14:59:38 GMT 2023 , Edited by admin on Fri Dec 15 14:59:38 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL2110992
Created by
admin on Fri Dec 15 14:59:38 GMT 2023 , Edited by admin on Fri Dec 15 14:59:38 GMT 2023
|
PRIMARY | |||
|
124-92-5
Created by
admin on Fri Dec 15 14:59:38 GMT 2023 , Edited by admin on Fri Dec 15 14:59:38 GMT 2023
|
PRIMARY | |||
|
m7497
Created by
admin on Fri Dec 15 14:59:38 GMT 2023 , Edited by admin on Fri Dec 15 14:59:38 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID10154184
Created by
admin on Fri Dec 15 14:59:38 GMT 2023 , Edited by admin on Fri Dec 15 14:59:38 GMT 2023
|
PRIMARY | |||
|
C83964
Created by
admin on Fri Dec 15 14:59:38 GMT 2023 , Edited by admin on Fri Dec 15 14:59:38 GMT 2023
|
PRIMARY | |||
|
C046877
Created by
admin on Fri Dec 15 14:59:38 GMT 2023 , Edited by admin on Fri Dec 15 14:59:38 GMT 2023
|
PRIMARY | |||
|
6O34Q1K8M6
Created by
admin on Fri Dec 15 14:59:38 GMT 2023 , Edited by admin on Fri Dec 15 14:59:38 GMT 2023
|
PRIMARY | |||
|
16057830
Created by
admin on Fri Dec 15 14:59:38 GMT 2023 , Edited by admin on Fri Dec 15 14:59:38 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |